Association of blood levels of urokinase plasminogen activator and its soluble receptor with prostate cancer presence, invasion, progression, and metastasis

被引：0
|
作者：
Shariat, S.
McConnell, J.
Park, S.
Wheeler, T.
Slawin, K.
Roehrborn, C.
机构：
[1] Univ Texas SW, Dallas, TX USA
[2] Baylor Coll Med, Houston, TX 77030 USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2007年 / 6卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(07)60903-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：249 / 249
页数：1
相关论文
共 50 条
  • [31] Targeting the Urokinase Plasminogen Activator Receptor Inhibits Ovarian Cancer Metastasis
    Kenny, Hilary A.
    Leonhardt, Payton
    Ladanyi, Andras
    Yamada, S. Diane
    Montag, Anthony
    Im, Hae Kyung
    Jagadeeswaran, Sujatha
    Shaw, David E.
    Mazar, Andrew P.
    Lengyel, Ernst
    CLINICAL CANCER RESEARCH, 2011, 17 (03) : 459 - 471
  • [32] Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia
    Toldi, Gergely
    Biro, Edina
    Szalay, Balazs
    Stenczer, Balazs
    Molvarec, Attila
    Rigo, Janos, Jr.
    Vasarhelyi, Barna
    Beko, Gabriella
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (11) : 1873 - 1876
  • [33] Soluble Urokinase-Type Plasminogen Activator Receptor Levels in Patients With Schizophrenia
    Nielsen, Jimmi
    Roge, Rasmus
    Pristed, Sofie Gry
    Viuff, Anne Grethe
    Ullum, Henrik
    Thorner, Lise Wegner
    Werge, Thomas
    Vang, Torkel
    SCHIZOPHRENIA BULLETIN, 2015, 41 (03) : 764 - 771
  • [34] Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in ankylosing spondylitis
    Toldi, Gergely
    Szalay, Balazs
    Beko, Gabriella
    Kovacs, Laszlo
    Vasarhelyi, Barna
    Balog, Attila
    JOINT BONE SPINE, 2013, 80 (01) : 96 - 98
  • [35] Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients with Heart Failure
    Hayek, Salim S.
    Tahhan, Ayman Samman
    Ko, Yi-An
    Alkhoder, Ayman
    Zheng, Shuai
    Bhimani, Ravila
    Hartsfield, Joy
    Kim, Jonathan
    Wilson, Peter
    Shaw, Leslee
    Wei, Changli
    Reiser, Jochen
    Quyyumi, Arshed A.
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (02) : 158 - 167
  • [36] Serum soluble urokinase-type plasminogen activator receptor (suPAR) is a useful marker of prostate cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 275 - 275
  • [37] The urokinase-type plasminogen activator and its receptor in cancer
    Rosenberg, S
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 121 - 128
  • [38] Soluble urokinase plasminogen activator receptor informs on the progression course after multiple injuries
    Patrani, Maria
    Tsaganos, Thomas
    Kotzampassi, Katerina
    Paraschos, Michael
    Katsenos, Chrysostomos
    Giamarellos-Bourboulis, Evangelos J.
    Mandragos, Konstantinos
    BIOMARKERS, 2016, 21 (07) : 660 - 664
  • [39] Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) as a possible biomarker for lung cancer and/or COPD
    Loukeri, Angeliki
    Spithakis, Panagiotis-Dimitrios
    Moschos, Charalampos
    Loukeri, Pinelopi
    Bartzeliotou, Anastasia
    Tzagkaraki, Aikaterini
    Stratos, Eustratios
    Veldekis, Dimitrios
    Kampolis, Christos F.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [40] Targeting of urokinase-type plasminogen activator receptor in oral cancer cells inhibits invasion and metastasis in vivo
    Nozaki, Shinichi
    Endo, Yoshio
    Nakahara, Hirokazu
    Yoshizawa, Kunio
    Hashiba, Yukari
    Kawashiri, Shuichi
    Tanaka, Akira
    Nakagawa, Kiyomasa
    Yamamoto, Etsuhide
    CANCER RESEARCH, 2006, 66 (08)
12345